Funder: Dept. of the Army -- USAMRAA
Due Dates: July 1, 2025 (Pre-Application) | October 6, 2025 (Full Application, by invitation)
Funding Amounts: Up to $490,000 total costs (direct + indirect) per award | Up to 3 years | ~14 awards, $6.86M total program
Summary: Supports early-stage, high-impact research on rare cancers with required preliminary data and strong disease rationale.
Key Information: Clinical trials are not allowed; research must address at least one of three focus areas (biology, pre-clinical models, therapy).